Cargando…

Advances in Renal Cell Carcinoma Drug Resistance Models

Renal cell carcinoma (RCC) is the most common form of kidney cancer. Systemic therapy is the preferred method to eliminate residual cancer cells after surgery and prolong the survival of patients with inoperable RCC. A variety of molecular targeted and immunological therapies have been developed to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiang, Yien, Zheng, Ge, Zhong, Jianfeng, Sheng, Jiyao, Qin, Hanjiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128023/ https://www.ncbi.nlm.nih.gov/pubmed/35619895 http://dx.doi.org/10.3389/fonc.2022.870396

Ejemplares similares

Mitochondrial Quality Control in Hepatocellular Carcinoma
por: Bian, Jinda, et al.
Publicado: (2021)

The Application Progress of Patient-Derived Tumor Xenograft Models After Cholangiocarcinoma Surgeries
por: Wu, Jun, et al.
Publicado: (2021)

Drug-Resistant Epilepsy and Surgery
por: Sheng, Jiyao, et al.
Publicado: (2018)

Precision diagnosis of hepatocellular carcinoma
por: Wang, Zhenxiao, et al.
Publicado: (2023)

Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations
por: Xie, Yingjun, et al.
Publicado: (2018)

Role of tumor-derived exosomes in metastasis, drug resistance and diagnosis of clear cell renal cell carcinoma
por: Jiang, Tiancheng, et al.
Publicado: (2022)

Paraneoplastic Hypereosinophilia in Locally Advanced Clear Cell Renal Carcinoma
por: Ellez, Halil İbrahim, et al.
Publicado: (2023)

A nomogram based on the preoperative neutrophil-to-lymphocyte ratio to distinguish sarcomatoid renal cell carcinoma from clear cell renal cell carcinoma
por: Wu, Yijian, et al.
Publicado: (2023)

Editorial: Advances in chemotherapy-resistant hepatocellular carcinoma
por: Liu, Shui, et al.
Publicado: (2023)

Current Status of Tivozanib in the Treatment of Patients With Advanced Renal Cell Carcinoma
por: Sakellakis, Minas, et al.
Publicado: (2023)

The impact of PI3K inhibitors on breast cancer cell and its tumor microenvironment
por: Qin, Hanjiao, et al.
Publicado: (2018)

Case Report: A MiT family translocation renal cell carcinoma in the renal pelvis, calyces and upper ureter misdiagnosed as upper tract urothelial carcinoma
por: Zou, Yuhua, et al.
Publicado: (2023)

Astragaloside in cancer chemoprevention and therapy
por: Wang, Yaning, et al.
Publicado: (2023)

Recent Advances in Herbal Medicines for Digestive System Malignancies
por: Sheng, Jiyao, et al.
Publicado: (2018)

Editorial: Molecular genetics and therapeutic advances in renal carcinoma
por: Nanus, David M., et al.
Publicado: (2023)

Third Generation Tyrosine Kinase Inhibitors and Their Development in Advanced Renal Cell Carcinoma
por: Bukowski, Ronald M.
Publicado: (2012)

Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach
por: Shinder, Brian M., et al.
Publicado: (2017)

T.H.R.O.B.V.S. Score – A Comprehensive Model to Predict the Surgical Complexity of Renal Cell Carcinoma With Tumor Thrombus
por: Wang, Kai, et al.
Publicado: (2022)

Observation as a treatment strategy for advanced renal cell carcinoma—a call for prospective validation
por: Fisher, Rosalie, et al.
Publicado: (2012)

Advanced Renal-Cell Carcinoma Pseudoprogression After Combined Immunotherapy: Case Report and Literature Review
por: Zhang, Xiaojie, et al.
Publicado: (2021)

Exosomal Circsafb2 Reshaping Tumor Environment to Promote Renal Cell Carcinoma Progression by Mediating M2 Macrophage Polarization
por: Huang, Xin, et al.
Publicado: (2022)

Advances in the Study of CircRNAs in Tumor Drug Resistance
por: Wang, Song, et al.
Publicado: (2022)

Significance of PTEN Mutation in Cellular Process, Prognosis, and Drug Selection in Clear Cell Renal Cell Carcinoma
por: Fan, Caibin, et al.
Publicado: (2019)

An Effective Hypoxia-Related Long Non-Coding RNAs Assessment Model for Prognosis of Clear Cell Renal Carcinoma
por: Zhang, Han, et al.
Publicado: (2021)

Editorial: Establishment of marker models for molecular typing of renal cell carcinoma
por: Jiang, Aimin, et al.
Publicado: (2023)

Selection of Optimal Candidates for Cytoreductive Nephrectomy in Patients with Metastatic Clear Cell Renal Cell Carcinoma: A Predictive Model Based on SEER Database
por: Zhang, Yishan, et al.
Publicado: (2022)

Hypophysitis induced by ipilimumab and nivolumab combination therapy for advanced renal cell carcinoma: A case report
por: Motonaga, Aoi, et al.
Publicado: (2021)

Cost-Effectiveness of Lenvatinib Plus Pembrolizumab or Everolimus as First-Line Treatment of Advanced Renal Cell Carcinoma
por: Wang, Ye, et al.
Publicado: (2022)

Comprehensive immune profiling of patients with advanced urothelial or renal cell carcinoma receiving immune checkpoint blockade
por: Lavoie, Jean-Michel, et al.
Publicado: (2022)

Tumor Enucleation vs. Partial Nephrectomy for T1 Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
por: Xu, Congcong, et al.
Publicado: (2019)

Automated Classification of Papillary Renal Cell Carcinoma and Chromophobe Renal Cell Carcinoma Based on a Small Computed Tomography Imaging Dataset Using Deep Learning
por: Zuo, Teng, et al.
Publicado: (2021)

Synchronous Renal Neoplasm: Clear Cell Renal Cell Carcinoma and Papillary Urothelial Carcinoma in the Same Kidney
por: Benavides-Huerto, Miguel Armando, et al.
Publicado: (2017)

Antibody-drug conjugates and predictive biomarkers in advanced urothelial carcinoma
por: Fenton, Sarah E., et al.
Publicado: (2023)

EI24 Inhibits Cell Proliferation and Drug Resistance of Esophageal Squamous Cell Carcinoma
por: Duan, Lili, et al.
Publicado: (2020)

Tumor Seeding With Renal Cell Carcinoma After Renal Biopsy
por: Andersen, M.F.B., et al.
Publicado: (2016)

Cross fused renal ectopia with associated renal cell carcinoma
por: Vyas, Paulas, et al.
Publicado: (2018)

Large renal artery aneurysm masquerading as renal cell carcinoma
por: Neerhut, Thomas, et al.
Publicado: (2022)

A case of sarcomatoid renal collecting duct carcinoma with paraneoplastic syndrome and peripheral adhesions
por: He, Xiang, et al.
Publicado: (2020)

Editorial: Immunotherapy in renal cell carcinoma
por: Gruenwald, Viktor, et al.
Publicado: (2022)

Prognostic Value of Vimentin Is Associated With Immunosuppression in Metastatic Renal Cell Carcinoma
por: Yao, Jia xi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s9d5m1gpmd450g8n6vb5fmr1i6